clioquinol has been researched along with tolnaftate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Knüsel, F; Weirich, EG | 1 |
| Barba-Rubio, J; Calle-Vélez, G; Dominguez-Soto, L; Londoño, F | 1 |
| Bassiouny, A; Hendawy, DS; Maher, A; Moawad, MK | 1 |
| Aguirre, A; Díaz Pérez, JL; Eizaguirre, X; González Pérez, R; Oleaga, JM | 1 |
| Loock, JW | 1 |
| Fahmy, NM; Lotfy, HM | 1 |
2 trial(s) available for clioquinol and tolnaftate
| Article | Year |
|---|---|
Comparative merits of two topical corticosteroid antimicrobial drugs.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone Valerate; Candidiasis, Cutaneous; Clinical Trials as Topic; Clioquinol; Female; Gentamicins; Halcinonide; Humans; Male; Neomycin; Nystatin; Random Allocation; Skin Diseases, Infectious; Tolnaftate | 1981 |
A randomised controlled trial of active chronic otitis media comparing courses of eardrops versus one-off topical treatments suitable for primary, secondary and tertiary healthcare settings.
Topics: Acetic Acid; Administration, Topical; Adult; Analysis of Variance; Anti-Infective Agents; Audiometry; Betamethasone Valerate; Boric Acids; Chi-Square Distribution; Chronic Disease; Ciprofloxacin; Clioquinol; Drug Resistance, Bacterial; Female; Gentamicins; Hearing Loss; Humans; Male; Otitis Media; Prospective Studies; Tolnaftate; Treatment Outcome | 2012 |
5 other study(ies) available for clioquinol and tolnaftate
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Microbiological evaluation of salicyclic acid and other broad spectrum antimicrobials].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Arthrodermataceae; Bacitracin; Bacteria; Candida albicans; Clioquinol; Escherichia coli; Gentamicins; Humans; Infections; Microbial Sensitivity Tests; Natamycin; Salicylates; Skin Diseases; Staphylococcus; Tolnaftate; Trichophyton; Undecylenic Acids; Yeasts | 1972 |
Otomycosis: an experimental evaluation of six antimycotic agents.
Topics: Antifungal Agents; Clioquinol; Clotrimazole; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Natamycin; Otitis Externa; Polymyxin B; Thiourea; Tolnaftate; Yeasts | 1982 |
Allergic contact dermatitis from tolnaftate.
Topics: Clioquinol; Dermatitis, Allergic Contact; Humans; Male; Middle Aged; Tolnaftate | 1995 |
Coupling of liquid-liquid extraction and mathematical filtration techniques for the separation and quantification of five components in semisolid dosage form with severely overlapped spectra.
Topics: Analysis of Variance; Betamethasone; Calibration; Chloroform; Clioquinol; Drug Compounding; Filtration; Gentamicins; Limit of Detection; Liquid-Liquid Extraction; Models, Theoretical; Reproducibility of Results; Solvents; Spectrophotometry; Tolnaftate | 2020 |